JPWO2023136329A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2023136329A5 JPWO2023136329A5 JP2023574092A JP2023574092A JPWO2023136329A5 JP WO2023136329 A5 JPWO2023136329 A5 JP WO2023136329A5 JP 2023574092 A JP2023574092 A JP 2023574092A JP 2023574092 A JP2023574092 A JP 2023574092A JP WO2023136329 A5 JPWO2023136329 A5 JP WO2023136329A5
- Authority
- JP
- Japan
- Prior art keywords
- delete
- cell
- allose
- cell cycle
- cancer cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004027 cell Anatomy 0.000 claims 5
- 230000022131 cell cycle Effects 0.000 claims 4
- 230000010261 cell growth Effects 0.000 claims 3
- 239000003340 retarding agent Substances 0.000 claims 3
- 208000003174 Brain Neoplasms Diseases 0.000 claims 2
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 claims 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 201000002528 pancreatic cancer Diseases 0.000 claims 2
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 2
- FBPFZTCFMRRESA-FBXFSONDSA-N Allitol Chemical group OC[C@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-FBXFSONDSA-N 0.000 claims 1
- 150000000715 D-allose derivatives Chemical class 0.000 claims 1
- 230000004663 cell proliferation Effects 0.000 claims 1
- 230000002414 glycolytic effect Effects 0.000 claims 1
- 239000007954 growth retardant Substances 0.000 claims 1
- 210000004881 tumor cell Anatomy 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022004569 | 2022-01-14 | ||
| PCT/JP2023/000825 WO2023136329A1 (ja) | 2022-01-14 | 2023-01-13 | 細胞増殖遅延剤、それを含む化粧品、及び細胞増殖を遅延させる方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023136329A1 JPWO2023136329A1 (https=) | 2023-07-20 |
| JPWO2023136329A5 true JPWO2023136329A5 (https=) | 2024-11-05 |
Family
ID=87279239
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023574092A Pending JPWO2023136329A1 (https=) | 2022-01-14 | 2023-01-13 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20250082658A1 (https=) |
| EP (1) | EP4464322A4 (https=) |
| JP (1) | JPWO2023136329A1 (https=) |
| WO (1) | WO2023136329A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118064508B (zh) * | 2024-04-25 | 2024-07-23 | 诸城市浩天生物科技有限公司 | 一种采用d-阿洛酮糖母液制备蒜糖醇的工艺方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1668735A (zh) * | 2002-05-22 | 2005-09-14 | 国立大学法人香川大学 | 稀有糖的生物活性的利用方法及配合了稀有糖的组合物 |
| KR100972696B1 (ko) * | 2008-04-24 | 2010-07-27 | 경상대학교산학협력단 | 호르몬 불감성 전립선암 세포주에 아폽토시스를 유도하는알로스 |
| US9109266B2 (en) | 2009-03-30 | 2015-08-18 | Matsutani Chemical Industry Co., Ltd. | Process of producing sugar composition comprising D-psicose and D-allose via strong alkaline isomerization of D-glucose/D-fructose or alkaline pre-treatment of D-glucose/D-fructose followed by isomerization in the presence of a basic ion exchange resin |
| JPWO2016152293A1 (ja) * | 2015-03-20 | 2018-03-01 | 国立大学法人 香川大学 | 癌細胞のｇｌｕｔ１の発現抑制用組成物および発現抑制方法 |
| US20220152068A1 (en) * | 2019-03-20 | 2022-05-19 | National University Corporation Kagawa University | Drug delivery carrier utilizing property of d-allose being uptaken by cancer cell, drug delivery method, and composition for treating renal cell carcinoma |
| CN113631175A (zh) | 2019-03-26 | 2021-11-09 | 国立大学法人香川大学 | 以阿洛糖醇为有效成分的抗肥胖活性剂和肥胖抑制方法 |
-
2023
- 2023-01-13 US US18/728,608 patent/US20250082658A1/en active Pending
- 2023-01-13 JP JP2023574092A patent/JPWO2023136329A1/ja active Pending
- 2023-01-13 EP EP23740337.3A patent/EP4464322A4/en active Pending
- 2023-01-13 WO PCT/JP2023/000825 patent/WO2023136329A1/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2011104570A (ru) | КОМБИНАЦИЯ (А) ИНГИБИТОРА ФОСФОИНОЗИТ-3-КИНАЗЫ И (Б) МОДУЛЯТОРА ПУТИ Ras/Raf/Mek | |
| JP2016538271A5 (https=) | ||
| JP2021091695A5 (https=) | ||
| BR112015009504A2 (pt) | inibidores de rock | |
| JP2017527532A5 (https=) | ||
| JP2016536286A5 (https=) | ||
| JP2017533221A5 (https=) | ||
| ES2877712T3 (es) | Terapias combinadas para su uso en el tratamiento del cáncer de mama | |
| JP2024516363A5 (https=) | ||
| JPWO2023136329A5 (https=) | ||
| KR20200123137A (ko) | 삼치환 벤조트리아졸 유도체의 사용 방법 | |
| JP2009542581A5 (https=) | ||
| JP2023530750A (ja) | 代謝を緩徐化するための補酵素アンタゴニストの使用 | |
| JP2005522527A5 (https=) | ||
| JP2017528505A5 (https=) | ||
| JP2013511526A5 (https=) | ||
| AR007021A1 (es) | Derivados de 3-descladinosa-2,3-anhidroeritromicina, procedimientos para su preparacion, compuestos para su exclusivo uso en dichos procedimientosy procedimiento para su preparacion, una composicion farmaceutica para tratar infecciones bacterianas y el uso de estos compuestos para preparar medicamentos | |
| JP2016515550A5 (https=) | ||
| AU2014236370B2 (en) | 5-bromo-indirubins | |
| CN102821605A (zh) | 改进的稳定的（e）-4-羧基苯乙烯基-4-氯苄基砜水性制剂 | |
| JP2018520197A5 (https=) | ||
| RO128004A0 (ro) | Compoziţie farmaceutică cu eliberare prelungită a trimetazidinei | |
| Kruzliak et al. | New perspectives of nitric oxide donors in cardiac arrest and cardiopulmonary resuscitation treatment | |
| CN116236490A (zh) | 脱氧胆酸的用途及药物 | |
| CN103655502A (zh) | 一种宠物用匹莫苯丹缓释片及其制备方法 |